Lupin Limited (LUPIN.NS)
INR 1969.25
(2.58%)
INR 1969.25
(2.58%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 19.14 Billion INR | 345.15% |
| 2022 | 4.3 Billion INR | 128.15% |
| 2021 | -15.28 Billion INR | -225.61% |
| 2020 | 12.16 Billion INR | 551.59% |
| 2019 | -2.69 Billion INR | -144.41% |
| 2018 | 6.06 Billion INR | 141.4% |
| 2017 | 2.51 Billion INR | -90.18% |
| 2016 | 25.57 Billion INR | 12.63% |
| 2015 | 22.7 Billion INR | -5.52% |
| 2014 | 24.03 Billion INR | 30.87% |
| 2013 | 18.36 Billion INR | 39.74% |
| 2012 | 13.14 Billion INR | 51.46% |
| 2011 | 8.67 Billion INR | 0.59% |
| 2010 | 8.62 Billion INR | 26.54% |
| 2009 | 6.81 Billion INR | 35.91% |
| 2008 | 5.01 Billion INR | 22.85% |
| 2007 | 4.08 Billion INR | 32.31% |
| 2006 | 3.08 Billion INR | 78.37% |
| 2005 | 1.72 Billion INR | 87.58% |
| 2004 | 922.2 Million INR | -33.8% |
| 2003 | 1.39 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 8.01 Billion INR | 122.94% |
| 2023 Q1 | 4.52 Billion INR | 91.67% |
| 2023 Q4 | 3.59 Billion INR | -41.38% |
| 2023 FY | 19.14 Billion INR | 345.15% |
| 2023 Q3 | 6.13 Billion INR | 25.21% |
| 2023 Q2 | 4.89 Billion INR | 8.27% |
| 2022 Q3 | 1.53 Billion INR | 18.3% |
| 2022 FY | 4.3 Billion INR | 128.15% |
| 2022 Q1 | -890.8 Million INR | 82.8% |
| 2022 Q2 | 1.29 Billion INR | 245.63% |
| 2022 Q4 | 2.35 Billion INR | 53.75% |
| 2021 FY | -15.28 Billion INR | -225.61% |
| 2021 Q3 | 5.45 Billion INR | 126.0% |
| 2021 Q1 | 5.42 Billion INR | 17.83% |
| 2021 Q4 | -5.17 Billion INR | -194.95% |
| 2021 Q2 | -20.98 Billion INR | -486.76% |
| 2020 Q1 | 1.06 Billion INR | -72.56% |
| 2020 Q2 | 2.11 Billion INR | 97.4% |
| 2020 Q3 | 4.38 Billion INR | 107.68% |
| 2020 FY | 12.16 Billion INR | 551.59% |
| 2020 Q4 | 4.6 Billion INR | 5.05% |
| 2019 Q3 | -8.35 Billion INR | -557.12% |
| 2019 Q4 | 3.89 Billion INR | 146.66% |
| 2019 Q2 | -1.27 Billion INR | -141.93% |
| 2019 Q1 | 3.03 Billion INR | 4.66% |
| 2019 FY | -2.69 Billion INR | -144.41% |
| 2018 Q3 | -1.51 Billion INR | -157.05% |
| 2018 FY | 6.06 Billion INR | 141.4% |
| 2018 Q4 | 2.89 Billion INR | 290.81% |
| 2018 Q1 | 2.02 Billion INR | 125.88% |
| 2018 Q2 | 2.65 Billion INR | 31.18% |
| 2017 Q4 | -7.83 Billion INR | -453.38% |
| 2017 Q3 | 2.21 Billion INR | -51.27% |
| 2017 Q2 | 4.55 Billion INR | 27.08% |
| 2017 Q1 | 3.58 Billion INR | -5.83% |
| 2017 FY | 2.51 Billion INR | -90.18% |
| 2016 Q1 | 8.81 Billion INR | 17.93% |
| 2016 Q4 | 3.8 Billion INR | -39.95% |
| 2016 Q3 | 6.33 Billion INR | -4.39% |
| 2016 Q2 | 6.62 Billion INR | -24.92% |
| 2016 FY | 25.57 Billion INR | 12.63% |
| 2015 Q1 | 5.25 Billion INR | -4.02% |
| 2015 Q2 | 4.08 Billion INR | -22.13% |
| 2015 FY | 22.7 Billion INR | -5.52% |
| 2015 Q3 | 5.29 Billion INR | 29.57% |
| 2015 Q4 | 7.47 Billion INR | 41.18% |
| 2014 Q1 | 6.24 Billion INR | 12.97% |
| 2014 FY | 24.03 Billion INR | 30.87% |
| 2014 Q2 | 6.3 Billion INR | 0.85% |
| 2014 Q4 | 5.47 Billion INR | -9.05% |
| 2014 Q3 | 6.01 Billion INR | -4.54% |
| 2013 Q4 | 5.53 Billion INR | 16.14% |
| 2013 Q3 | 4.76 Billion INR | 17.22% |
| 2013 Q2 | 4.06 Billion INR | 1.28% |
| 2013 Q1 | 4.01 Billion INR | -1.72% |
| 2013 FY | 18.36 Billion INR | 39.74% |
| 2012 Q3 | 3.35 Billion INR | 15.41% |
| 2012 FY | 13.14 Billion INR | 51.46% |
| 2012 Q4 | 4.08 Billion INR | 21.73% |
| 2012 Q1 | 2.8 Billion INR | 80.15% |
| 2012 Q2 | 2.9 Billion INR | 3.59% |
| 2011 Q4 | 1.55 Billion INR | -33.79% |
| 2011 FY | 8.67 Billion INR | 0.59% |
| 2011 Q3 | 2.35 Billion INR | 0.0% |
| 2010 FY | 8.62 Billion INR | 26.54% |
| 2009 FY | 6.81 Billion INR | 35.91% |
| 2008 FY | 5.01 Billion INR | 22.85% |
| 2007 FY | 4.08 Billion INR | 32.31% |
| 2006 FY | 3.08 Billion INR | 78.37% |
| 2005 FY | 1.72 Billion INR | 87.58% |
| 2004 FY | 922.2 Million INR | -33.8% |
| 2003 FY | 1.39 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -210.883% |
| Hester Biosciences Limited | 188.89 Million INR | -10035.423% |
| Aarti Drugs Limited | 1.71 Billion INR | -1016.848% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -782.647% |
| Albert David Limited | 754.2 Million INR | -2438.421% |
| Alembic Limited | 2.68 Billion INR | -612.712% |
| Alkem Laboratories Limited | 17.95 Billion INR | -6.611% |
| Bafna Pharmaceuticals Limited | 73.47 Million INR | -25954.791% |
| Bajaj HealthCare Limited | -837.93 Million INR | 2384.77% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -269849.239% |
| Brooks Laboratories Limited | -195.91 Million INR | 9871.793% |
| Eris Lifesciences Limited | 3.91 Billion INR | -388.409% |
| FDC Limited | 3.05 Billion INR | -527.239% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -306.568% |
| Gufic Biosciences Limited | 861.35 Million INR | -2122.635% |
| Hikal Limited | 696 Million INR | -2650.69% |
| Ind-Swift Limited | 142.31 Million INR | -13352.601% |
| Innova Captab Limited | 943.45 Million INR | -1929.233% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -1324.146% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -8422.815% |
| Jubilant Pharmova Limited | 771 Million INR | -2383.113% |
| Lincoln Pharmaceuticals Limited | 933.04 Million INR | -1951.854% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 21203.872% |
| Medico Remedies Limited | 82.9 Million INR | -22991.341% |
| Morepen Laboratories Limited | 961.59 Million INR | -1890.934% |
| Nectar Lifesciences Limited | 49.95 Million INR | -38227.928% |
| Orchid Pharma Limited | 921.66 Million INR | -1977.197% |
| Procter & Gamble Health Limited | 2 Billion INR | -852.572% |
| RPG Life Sciences Limited | 876.6 Million INR | -2083.984% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -13011.619% |
| Sigachi Industries Limited | 571.8 Million INR | -3248.152% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 437.419% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -537.564% |
| Themis Medicare Limited | 435.23 Million INR | -4298.697% |
| Unichem Laboratories Limited | -704.74 Million INR | 2816.565% |
| Vaishali Pharma Limited | 7.18 Million INR | -266206.858% |
| Wanbury Limited | 559.56 Million INR | -3321.384% |
| Windlas Biotech Limited | 581.87 Million INR | -3190.219% |
| ZIM Laboratories Limited | 172.46 Million INR | -11000.751% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -354.787% |
| Ipca Laboratories Limited | 5.47 Billion INR | -249.773% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 80.008% |
| Venus Remedies Limited | 284.9 Million INR | -6619.643% |
| Sakar Healthcare Limited | 116.7 Million INR | -16303.876% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 39.663% |
| Divi's Laboratories Limited | 16 Billion INR | -19.655% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -1085.363% |
| Mankind Pharma Limited | 19.12 Billion INR | -0.083% |
| Sequent Scientific Limited | -358.69 Million INR | 5437.422% |
| Laurus Labs Limited | 1.6 Billion INR | -1092.451% |
| Neuland Laboratories Limited | 3 Billion INR | -537.992% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -246.432% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 227.49% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 50.396% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -4156.992% |
| Wockhardt Limited | -4.63 Billion INR | 513.495% |
| Bal Pharma Limited | 73.92 Million INR | -25798.65% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 65.619% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -2437.278% |
| Par Drugs and Chemicals Limited | 145.01 Million INR | -13102.4% |
| Caplin Point Laboratories Limited | 4.57 Billion INR | -318.841% |
| Shilpa Medicare Limited | 318.74 Million INR | -5906.363% |
| Valiant Laboratories Limited | 3.19 Million INR | -598923.78% |
| Ajanta Pharma Limited | 8.16 Billion INR | -134.569% |
| Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -40775.663% |
| Granules India Limited | 4.05 Billion INR | -372.35% |
| Medicamen Biotech Limited | 109.31 Million INR | -17414.226% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -7462.87% |
| Piramal Enterprises Limited | -16.83 Billion INR | 213.718% |
| Torrent Pharmaceuticals Limited | 16.56 Billion INR | -15.582% |
| NATCO Pharma Limited | 13.88 Billion INR | -37.901% |
| Suven Life Sciences Limited | -1.05 Billion INR | 1921.99% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 9804.183% |
| Strides Pharma Science Limited | -706.14 Million INR | 2811.19% |
| Indoco Remedies Limited | 984.6 Million INR | -1844.422% |
| Alpa Laboratories Limited | 167.76 Million INR | -11311.677% |
| Lasa Supergenerics Limited | -217.3 Million INR | 8910.065% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 594.424% |